RxDoctor Payments DataLook up a doctor →

Kimberly Schwerdtfeger, NP

Nurse Practitioner · Mount Pleasant, WINPI 1235414665

Payments from drug & device makers

$14,673in general payments, 2019–2025

Across 731 payments — averaging $20.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Regeneron Healthcare Solutions, Inc.$2K
  • Lilly USA, LLC$1K
  • Sun Pharmaceutical Industries Inc.$1K
  • Amgen$1K
  • Johnson & Johnson$1K
  • plus $6K from 28 others

What the payments were for

  • Food & beverage$13,78194%
  • Education$8916%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,673 in reported general payments places this provider in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.

See all nurse practitioner providers in Wisconsin

Medicare billing

Part B allowed, 2024
$213,113
Medicare patients
502
Services billed
3,319

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa11$251,013
Humira(Cf) PenAdalimumab13$103,957
Clobetasol Propionate166$6,785
Fluorouracil43$3,095
Desonide62$2,742
Clindamycin Phosphate31$1,865
Ketoconazole106$1,758
Triamcinolone Acetonide68$1,113
Metronidazole17$1,013
Doxycycline Hyclate37$763
Mometasone Furoate18$340
Ciclopirox13$314
ValacyclovirValacyclovir Hcl20$132
Cephalexin11$76

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Mount Pleasant

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →